“PBT-SCREEN”, a high-throughput screening platform to identify new therapeutic agents for Medulloblastoma Group 3Inés Fallon(System Biosciences (United States)), D D Bigner(Duke University)Research SquareAugust 25, 202310.21203/rs.3.rs-3286730/v1Cited by 0SaveCiteExport RISWatch citationsRelated PapersComprehensive genomic characterization defines human glioblastoma genes and core pathways|Nature|2008|7.8kDevelopment of a high-throughput screening platform to identify new therapeutic agents for Medulloblastoma Group 3|SLAS DISCOVERY|2024|4